Literature DB >> 7051847

Insulin binding and action on fat cells from young healthy females and males.

O Pedersen, E Hjøllund, H O Lindskov.   

Abstract

Insulin binding and action were studied in fat cells from the gluteal region of young healthy subjects. Fat cells from females were larger than those of males, had higher insulin receptor binding and higher rates of noninsulin-stimulated and maximally insulin-stimulated rates of methylglucose transport and glucose metabolism when these data were expressed per cell number. However, when insulin binding and insulin effects were expressed per cell surface, which may be physiologically more relevant, no sex differences were found in insulin binding and glucose transport, whereas noninsulin-stimulated and maximally insulin-stimulated glucose metabolism was still significantly increased in female fat cells. The latter indicates postreceptor differences in glucose metabolism between females and males. The insulin concentrations causing half-maximal responses (a measure of the sensitivity to insulin) of glucose transport, glucose metabolism and lipolysis were similar in fat cells from the two sexes, which is consistent with the comparable values of insulin receptor binding when adjusted to cell surface. Studies of rate-determining steps for the glucose utilization of human fat cells showed that glucose transport was not the rate-limiting step at physiological glucose concentrations. Moreover, at physiological glucose levels, glucose metabolism exhibited a decreased maximal insulin responsiveness and an increased insulin sensitivity when compared with glucose metabolism at low glucose concentrations at which glucose transport is rate limiting for the fat cell glucose utilization.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051847     DOI: 10.1152/ajpendo.1982.243.2.E158

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

Review 1.  Insulin receptors and the clinician.

Authors:  R Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

Review 2.  Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases.

Authors:  Suresh Mishra; Bl Grégoire Nyomba
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-04

3.  Assay of glucose transport in human fat cells obtained by needle biopsy.

Authors:  H Yki-Järvinen; E A Nikkilä; K Kubo; J E Foley
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

4.  Biological effects of sulphated insulin in adipocytes and hepatocytes.

Authors:  S Zeuzem; R Taylor; L Agius; K Schoeffling; A M Albisser; K G Alberti
Journal:  Mol Cell Biochem       Date:  1985-10       Impact factor: 3.396

Review 5.  Metabolic actions of insulin in men and women.

Authors:  Faidon Magkos; Xuewen Wang; Bettina Mittendorfer
Journal:  Nutrition       Date:  2010-04-14       Impact factor: 4.008

6.  Increased insulin sensitivity and responsiveness of glucose metabolism in adipocytes from female versus male rats.

Authors:  M Guerre-Millo; A Leturque; J Girard; M Lavau
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Distribution of glucose transporters in membrane fractions isolated from human adipose cells. Relation to cell size.

Authors:  E Karnieli; A Barzilai; R Rafaeloff; M Armoni
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Long-term fat-feeding-induced insulin resistance in normal NMRI mice: postreceptor changes of liver, muscle and adipose tissue metabolism resembling those of type 2 diabetes.

Authors:  C J Hedeskov; K Capito; H Islin; S E Hansen; P Thams
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

Review 9.  Metabolic syndrome X: an inflammatory condition?

Authors:  Undurti N Das
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

10.  Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots.

Authors:  Kalypso Karastergiou; Susan K Fried; Hui Xie; Mi-Jeong Lee; Adeline Divoux; Marcus A Rosencrantz; R Jeffrey Chang; Steven R Smith
Journal:  J Clin Endocrinol Metab       Date:  2012-11-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.